Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06292104 · ClinicalTrials.gov registry record

Phenotyping of Postural Orthostatic Tachycardia Syndrome (POTS)

A clinical trial of Postural Orthostatic Tachycardia Syndrome, sponsored by University of Texas Southwestern Medical Center.

Recruiting
Registry status
350
Enrollment target
1
Study location

NCT06292104 is a study of Postural Orthostatic Tachycardia Syndrome that is actively recruiting participants, run by University of Texas Southwestern Medical Center. The registered enrollment target is 350 participants, below the 9,213-participant average among 11 other Postural Orthostatic Tachycardia Syndrome trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06292104, a study of Postural Orthostatic Tachycardia Syndrome, is actively recruiting participants, sponsored by University of Texas Southwestern Medical Center.

RECRUITING
Registry status
350 participants
Enrollment target
1
Study location

Study Summary

This is an observational study to deeply phenotype the disorder of POTS using multiple testing modalities.

Interventions

  • DIAGNOSTIC_TEST multimodal diagnostic testing

Study Locations (1)

Texas

  • UT Southwestern Medical Center - Dallas

Trial Details

FieldValue
Enrollment Target 350 participants
Start Date 2024-03-05
Est. Completion 2029-01

What the Registry Record Tells You About NCT06292104

The ClinicalTrials.gov registry entry for NCT06292104 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 350 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 9,213-participant average among 11 other Postural Orthostatic Tachycardia Syndrome trials with a reported enrollment target (96% lower). The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Postural Orthostatic Tachycardia Syndrome appearing as the primary indexed condition, and to 1 intervention - of which multimodal diagnostic testing is the first listed.

NCT06292104 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT06292104 about?

NCT06292104 is a clinical study titled "Phenotyping of Postural Orthostatic Tachycardia Syndrome (POTS)". This is an observational study to deeply phenotype the disorder of POTS using multiple testing modalities.

What is the current status of trial NCT06292104?

This trial is currently recruiting. The enrollment target is 350 participants. The study started on 2024-03-05. Estimated completion is 2029-01.

What conditions does trial NCT06292104 study?

This clinical trial studies the following conditions: Postural Orthostatic Tachycardia Syndrome.

What interventions are being tested in trial NCT06292104?

The interventions under investigation include: multimodal diagnostic testing (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT06292104?

This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06292104 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Postural Orthostatic Tachycardia Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.